You are here

  • Home
  • Archive
  • Volume 9, Issue 5
  • High dose atorvastatin was superior to standard dose pravastatin in reducing death or major CV events in acute coronary syndrome

Article Text

Article menu
Download PDFPDF
Therapeutics
High dose atorvastatin was superior to standard dose pravastatin in reducing death or major CV events in acute coronary syndrome

https://doi.org/10.1136/ebm.9.5.144

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ↵* See glossary.

    • For correspondence: Dr C P Cannon, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA. cpcannonpartners.org

    • Sources of funding: Bristol-Myers Squibb and Sankyo.